Background Alopecia areata is a disorder that results in nonscarring hair loss. The
psychological impact can be significant, leading to feelings of depression and social …

Introduction: This review aims to raise the potential of the modern society's impact on gut
integrity often leading to increased intestinal permeability, as a cause or driver of Alopecia …

Alopecia areata (AA) is a common autoimmune disease that results in non-scarring hair
loss. AA pathogenesis is thought to involve multiple inflammatory cytokines. Apremilast is a …

Little is known about the scalp bacterial composition of alopecia areata (AA) patients. The
aim of this study was to investigate the differences in the scalp microbiome of AA patients …

Abstract Interleukin-17 (IL-17) has been implicated in the pathogenesis of a large number of
inflammatory and autoimmune conditions, including skin disorders such as psoriasis …

Background: Cetuximab (CTX) is a glycosylated anti-EGFR monoclonal antibody of great
interest in the treatment of non-melanoma skin cancers. Its intravenous administration is …

Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex,
and disease severity Page 1 Advances in Dermatology and Allergology 6, December/2020 …

Background Trichoscopy is a useful tool for diagnosis and follow‐up of alopecia areata (AA)
patients. Both platelet‐rich plasma (PRP) and intralesional corticosteroids (ILCs) are …

Alopecia areata (AA) accounts for the autoimmune disorder mediated by T cells, whose
prognostic outcome cannot be predicted and curative treatment is unavailable at present …

The term “microbiome” defines the collective genome of all commensal, symbiotic, and
pathogenic microbes living in the human body. The composition of microbiota in the gut and …